The ability to quantitate early effects of tumor therapeutic response using noninvasive imaging would have a major impact in clinical oncology. One area of active research interest is the ability to use MR techniques to detect subtle changes in tumor cellular density. In this study, sodium and proton diffusion MRI were compared for their ability to detect early cellular changes in tumors treated with a cytotoxic chemotherapy. Subcutaneous 9L gliosarcomas were treated with a single dose of 1,3-bis(2-chloroethyl) -1-nitrosourea. Both sodium and diffusion imaging modalities were able to detect changes in tumor cellularity as early as 2 days after treatment, which continued to evolve as increased signal intensities reached a maximum~8 days posttreatment. Early changes in tumor sodium and apparent diffusion coefficient values were predictive of subsequent tumor shrinkage, which occurred~10 days later.
Introduction
Currently, there is significant interest in identifying biomarkers that are able to predict if a tumor will be responsive to a specific therapy before treatment using genomics/proteomics and during the course of treatment using imaging. Noninvasive imaging modalities have been increasingly investigated for their ability to provide early prediction of cancer treatment outcome. Because cellular changes can occur well in advance of tumor shrinkage [1] [2] [3] [4] , imaging approaches that are sensitive to cell viability could provide a unique window of opportunity allowing for the early prediction of treatment outcome.
Changes in tumor water apparent diffusion coefficients (ADCs) [1] [2] [3] [4] and sodium content are attracting increasing interest due to both preclinical and clinical success and from developments in high-magnetic-field technology . In this study, the subcutaneous 9L tumor model was used to evaluate Na MRI for detection of early chemotherapeutic changes as compared with diffusion MRI. Both imaging modalities were performed simultaneously over a 3-week period after a single dose of chemotherapy. We found excellent correlation between tumor tissue sodium content (TSC) and ADC values demonstrating the ability of both modalities to detect treatment-induced changes in tumor cell membrane integrity. The results of this study support the hypothesis that the correlation between chemotherapy-induced changes in ADC values and sodium levels using MRI is reflective of their sensitivity to changes in the intra/extracellular space, an inherent link with overall cell membrane integrity. However, both modalities do not necessarily always convey the same information for a given voxel as they provide independent measures of tumor microenvironment. During successful interventions, as observed during chemotherapy, tumor cell destruction occurs relatively quickly, initiating coherent changes in both TSC and ADC values. The early increases in ADC and TSC observed well before any volumetric decrease provide compelling evidence that these noninvasive imaging modalities can be used as predictive biomarkers of cancer therapeutic efficacy.
Materials and methods

Cell culture
Rat 9L gliosarcoma cells (Passage 12) from the Brain Tumor Research Center at the University of California at San Francisco were maintained and grown as monolayer cultures in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum, 100 IU/ml penicillin and 100 Ag/ml streptomycin at 37 8C in a normally humidified atmosphere containing 95%/5% air/CO 2 mixture. Before implantation, cells were grown to confluence in a 175-cm 2 flask, harvested using a 0.25% trypsin/0.1% EDTA solution and counted. Cells were pelleted (800Âg, 5 min), resuspended in serum-free DMEM at a concentration of~10 4 cells/Al and kept on ice until use. The 9L cells were carried only until Passage 40, at which time cells were reactivated from frozen stocks. Cell culture reagents were obtained from Invitrogen Life Technologies (Carlsbad, CA, USA).
Tumor implantation of animals
Male Fisher 344 rats weighing~75 g were obtained from Harlan (Indianapolis, IN, USA). Animals (N =12) were anesthetized by intraperitoneal injection using an 87%/13% (vol/vol) ketamine/xylazine mixture. Under aseptic conditions, the rats were injected subcutaneously in the right hindquarter (where the top of the leg and the body meet) with 50 Al of 9L cells (~10 4 cells/Al).
Chemotherapeutic treatment
Thirteen days after the tumor implantation, the 12 tumorbearing rats were divided into two groups: 7 rats for the treatment group and 5 for the control group. The rats' average tumor size at the time of treatment (13 days after tumor implantation) was~300 Al. The treated group received 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy. A standard 100-mg BCNU preparation (Bristol Lab) was dissolved in ethanol and subsequently in 100% saline solution according to the recommended procedure described in the instructions for preparation. Dissolved BCNU was immediately used for a single-dose intraperitoneal injection of 26.6 mg/kg. All animal experiments were conducted according to the protocols approved by the University of Michigan Committee on Use and Care of Animals.
MRI
Sodium and proton MRI were performed serially every 2 -3 days on all animals until sacrifice, when the tumor reached a volume of~2 cm 3 . Proton and sodium MR scans were performed using a 9.4-T Varian MR scanner (120-mm clear horizontal bore, Varian, Palo Alto, CA, USA) and a double-tuned volume radiofrequency (RF) coil with an internal diameter of 34 mm and a length of 65 mm (Doty Scientific, Columbia, SC, USA). Animal body temperature was maintained during MRI scans using a temperaturecontrolled circulating-water heating pad. Anesthesia was maintained using a 1.25% vol/vol isoflurane/air gas mixture.
Sodium MRI
The tumor region of each rat was placed at the center of the RF coil. The axial length of the RF homogenous region (F5%) was~20 mm, which was sufficient to encompass the spatial extent of the tumors and to allow quantitative tumor sodium imaging. Because sodium has short T2 relaxation time components, a three-dimensional (3D) back-projection pulse sequence was used. In the original spin-echo 3D backprojection pulse sequence (Varian), two hard pulses were providing an echo time of 1000 As. The other parameters were as follows: readout gradient 1.3 G/cm; field of view (FOV) 64Â64Â64 mm; sodium signal was acquired with 64 complex points in readout direction using 32Â32 projections; TR = 0.1 s; and scan time =28 min. Duration of the 908 pulse was 50 As. Sodium T1 relaxation time in normal rat muscle in our experiments was 37F1 ms at 9.4 T, thus yielding an almost unsaturated Na signal during 3D imaging. Back-projection reconstruction was performed using Matlab (V.7.0.1). Data were zero filled to 256 points before Fourier transform. The final output image matrix had 180Â180Â180 voxels for the sodium signal through the FOV.
Sodium tumor concentration was determined as an average for all voxels over the 3D volume of the tumor.
Proton MRI
The protocol for proton multislice diffusion MRI utilized an FOV of 40Â40 mm, an acquisition matrix of 128Â128, 15 slices, slice thickness of 1.5 mm, slice gap of 0.5 mm, TR of 3 s and TE of 40 ms. The diffusion spin-echo pulse sequence employed isotropic diffusion weighting by orthogonalization of x-, y-and z-gradient waveforms [28] . Specifically, the imaging plus diffusion gradient waveforms were designed to equalize diagonal elements and zero out off-diagonal elements of the b matrix. In addition, this sequence included first-order motion compensation and a 32-point navigator echo for phase correction before twodimensional Fourier transform image reconstruction. Diffusion-weighted images (DWIs) at two b-factor settings were acquired for calculation of ADC maps: high b (b = 1082 s/mm 2 ) and low b (b = 117 s/mm 2 ). Proton images and ADC maps were reconstructed in Matlab, and the tumor volume and average ADC values were determined over a 3D volume of interest (VOI) for each temporal measurement.
Quantification and analysis
Three-dimensional sodium images were coregistered to the target proton multislice DWI and ADC image set. Use of a double-tuned coil dramatically minimized the coregistration procedure. This process placed all images onto a common geometrical frame, allowing the tumor VOI definition to be performed on available higher-quality images that were registered to the quantitative images of interest (i.e., sodium and ADC).
For quantification of sodium measurements, Na MR signals were compared with several reference samples consisting of saline at 38, 77 and 154 mM. The size of these reference samples was adjusted to fill the working volume of the coil. The difference in RF coil loading between animals and reference samples was corrected by adjusting the sodium tumor signals with a reverse ratio of the corresponding sodium 908 pulse durations.
Each animal had Na MRI and ADC measurements performed in axial planes through the tumor and in the contralateral flank. Reproducibility of the imaging experimental conditions was assessed by stability of Na and ADC measurements in the contralateral region. The results of all ADC values and sodium concentrations are presented as averageFS.E.M.
Results
BCNU treatment of subcutaneous 9L tumors was monitored over time using diffusion and sodium MRI. A representative example of a diffusion map from an untreated 9L tumor is shown in Fig. 1A . Although some heterogeneity is observed, overall, the ADC maps reveal a lower diffusion value relative to the host muscle tissue. In contrast, the sodium levels of the tumor were well above the normal muscle tissue and increased somewhat over time as shown in Fig. 1B . For example, on Day 18 after tumor implantation, sodium images revealed increases in tumor sodium concentration (Fig. 1B) whereas diffusion values remained consistent. Diffusion maps of tumors with BCNU revealed a significant increase in ADC values on Day 8, which returned to pretreatment levels by Day 17 ( Fig. 2A) . Changes in tumor sodium content paralleled the changes observed in the ADC maps as shown in Fig. 2B .
A comparison of the tumor volumes for control versus treated tumors is provided in Fig. 3 . These data reveal that treatment with BCNU significantly inhibited the growth of the subcutaneous 9L tumor in the treated group versus the untreated group. In fact, tumor volume in untreated 9L tumors during the experiment increased eightfold (Fig. 3) , with a volumetric doubling time of 3.0F0.5 days.
Three days after treatment with BCNU, the average rate of ADC increase was~0.15Â10
À3 mm 2 /s/day (Fig. 4) . Thereafter, mean ADC reached a maximum of (1. (Figs. 4 and 5) . The initial rate of tumor sodium increase after BCNU injection was~5.6 mM/day. The average tumor sodium concentration reached a maximum of~100 mM on Day 8 after initiation of therapy. The initial tumor Na concentration in nontreated tumors was 42F2 mM (Fig. 5) . It is important to note that during 9 days of observation, tumor sodium in nontreated tumors also increased over time, as the tumor volume increased eightfold. For comparison, the Na concentration in a contralateral normal flank tissue was~20F2 mM, which is much less than that in tumor.
It was noted that, during tumor shrinkage, tumor ADC and sodium concentration were still elevated above pre-BCNU levels. Both sodium and ADC reached their pretreatment values on approximately Day 18 of posttreatment, which corresponded to the maximum regression of the tumor volume.
Comparison of changes in proton ADC values and sodium concentrations in subcutaneous tumors after therapy revealed an excellent correlation (Fig. 6) . The relationship between the two modalities was fitted by the equation [Na] mM =À19.9+65.1Â10
3 ÂADC, with a correlation coefficient (R) of .97. The total range of changes in tumor sodium concentration after therapy was from~40 mM (Day 0) to 100 mM (Day 8), whereas total changes in diffusion were from 1Â10
À3 mm 2 /s (Day 0) to 1.9Â10 À3 mm 2 /s (Day 8).
Discussion
This study presents evidence for the correlation of changes in TSC with those in ADC values during chemotherapy. The correspondence of temporal changes observed between sodium and ADC images for this tumor and, ultimately, their well-defined linear dependence (Fig. 4) support the hypothesis that this correlation could be a general phenomenon and that both modalities represent altered tumor cellularity during cancer treatment.
It is expected that sodium and ADCs have a similar capacity to reflect changes in cellularity during interventions. All functioning cells have a large transmembrane gradient of Na, with a low intracellular concentration (Na in =~15 mM) and a high extracellular concentration (Na ex =~140 mM). Because of the limited extracellular space in muscle, the average tissue Na concentration is 20 -30 mM, as can be derived from the data for intracellular Na in rat muscle [29] . Thus, disruption of the Na transmembrane gradient, as a result of interventions, could initiate a dramatic increase in tissue sodium to a maximum concentration up to the value found in extracellular space (~140 mM). A similar situation could occur for ADC, where loss of membrane function integrity leads to increased volume of extracellular space; thus, water mobility becomes less restricted and is reflected in tumor ADC values. If these cellular processes are initiated by tumor therapy, it is reasonable to assume that the corresponding changes in sodium and ADC values should have a temporal correlation. Our study demonstrated that both imaging modalities were capable of detecting dynamic therapeutically induced changes in tumors. This conclusion is also supported by recent MRI experiments on RIF-1 tumors treatment by cyclophosphamide [21] .
Data presented in this current work reveal that changes in Na and ADC tumor values after BCNU therapy could be detected 2-3 days after initiation of treatment, revealing that these measurements can serve as early therapeutic outcome biomarkers. In fact, treatment initiated a rapid rise in tumor sodium increase of~5.6 mM/day among the treated animals, as compared with the untreated animals that had an average rate of~2.7 mM/day. An increase of tumor sodium eventually could lead to a burst of tumor cells, detectable as an increase in a tumor's ADC and Na at the same time, which is a sign of the latest stages of cell death. In this regard, sodium MRI may deliver grading and prognostic information about tumors comparable with those of nuclear imaging methods [30] .
Conclusion
This study demonstrates that, using an animal model, there is an excellent correlation between tumor sodium and ADC during chemotherapy. The experiments support the hypothesis that this correlation could be a general phenomenon relevant for other tumors in other anatomical sites. The study reveals the ability of sodium MRI to perform the same diagnostic and predictive role during cancer therapy as does ADC mapping. Low sodium signal intensities have certain limitations on the resolution of sodium MRI. However, sodium images on 3-to 4-T MR scanners are already a reality. An advantage of sodium MRI is that it has less intensive susceptibility artifact, which is a valuable feature for any surface tumor and could provide a more robust quantitative approach in areas where cardiac or respiratory motion is a significant issue.
The results of this study support the current clinical trials of ADC as an indicator of tumor cellularity during cancer therapy and demonstrate the complementary possibility of using Na MRI. The future development of high-field scanners will further aid in facilitating the utilization of sodium MRI in clinical oncology.
